4//SEC Filing
ChemoCentryx, Inc. 4
Accession 0001209191-17-029817
CIK 0001340652operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 7:06 PM ET
Size
5.0 KB
Accession
0001209191-17-029817
Insider Transaction Report
Form 4
LUCAS ROGER C
Director
Transactions
- Sale
Common Stock
2017-05-01$7.31/sh−4,000$29,228→ 62,822 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.11 to $7.40 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
ChemoCentryx, Inc.
CIK 0001340652
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001340652
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 7:06 PM ET
- Size
- 5.0 KB